Summary

Amends the

to: establish the statutory authority for the publication of information in relation to the Pharmaceutical Benefits Advisory Committee, including meeting agendas, meeting outcomes, public summary documents and information published on the Medicine Status Website; and provide for cost recovery arrangements, including specifying fees for services and costs incurred to be set out in a disallowable legislative instrument, replacing the existing regulations; and make consequential amendments.